Terbinafine HCL 250 MG tablet 90S
Ended Awarded Last action
- Contract number
- SPE2DR26FQHU7
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,278
Award facts
- Contract value 100% obligated
- $5,278.20 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 325411 Medicinal and Botanical Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $5,278.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Terbinafine HCL 250 mg tablets (90-count). The delivery order, issued on January 16, 2026, with an ultimate completion date of January 20, 2026, carries no set-aside designation, indicating the contractor won this award through unrestricted federal procurement competition. This delivery order was issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.999 billion contract awarded in November 2025 that positions the company as a critical regional pharmaceutical supplier for Department of Defense healthcare operations.
The PPV-G GEN V program represents a broader $30.3 billion acquisition strategy designed to provide comprehensive pharmaceutical and medical consumable support to military healthcare facilities worldwide. DMS Pharmaceutical Group's portfolio encompasses an extensive range of products including branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals, with the company demonstrating substantial federal contracting capability through numerous prior delivery orders issued without set-aside restrictions. This delivery order exemplifies the operational execution of the larger PPV-G GEN V vehicle, enabling the Defense Logistics Agency to procure routine pharmaceutical requirements efficiently through established prime vendor relationships that support recurring medical supply needs across the military healthcare system.
Quick answers
Who was awarded contract SPE2DR26FQHU7?
SPE2DR26FQHU7 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 16, 2026.
How much is contract SPE2DR26FQHU7 worth?
The government has obligated $5,278 on SPE2DR26FQHU7.
Is contract SPE2DR26FQHU7 an order under another contract?
Yes. SPE2DR26FQHU7 is a delivery order under SPE2DR25D9759, an indefinite delivery contract.
Was contract SPE2DR26FQHU7 competed?
The extent of competition for SPE2DR26FQHU7 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award